Mode
Text Size
Log in / Sign up
Phase 3 Completed N=77 Randomized Treatment

Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?

Source: ClinicalTrials.gov NCT00853905 ↗
Enrolled (actual)
77
Serious AEs
0.0%
Results posted
Mar 2016
Primary outcomePrimary: Intraocular Pressure (IOP) — 16.1; 12.8; 11.7; 11.8 mm Hg
◆ Published Evidence
Emerging
10citations · ~1 / year
Intracameral triamcinolone acetonide in glaucoma surgery: a prospective randomized controlled trial.
American journal of ophthalmology · 2014 · High-confidence link

Summary

The investigators hypothesize that intracameral Triesence during glaucoma surgery will provide lower intraocular pressure through better control of ocular inflammation, thus leading to a more successful filtering procedure.

Linked Publications

  • Intracameral triamcinolone acetonide in glaucoma surgery: a prospective randomized controlled trial.
    American journal of ophthalmology · 2014 · 10 citations · High-confidence link

Outcome Measures

OutcomeResultp-value
PRIMARY
Intraocular Pressure (IOP)
16.1; 12.8; 11.7; 11.8; 16.1; 14.4
SECONDARY
Anterior Chamber Inflammation (Flare)
0.4; 1.0; 0.6; 0.4; 0.3; 0.2
SECONDARY
Bleb Appearance
1.7; 2.1; 1.7; 1.9; 2.2; 1.9
SECONDARY
Patient Comfort
0.3; 0.1; 0.6; 0.3; 0.3; 0.6
SECONDARY
Ocular Hypotensive Medications
0.03; 0.06; 0.1; 0.03; 0.08; 0.22

Eligibility Criteria

Inclusion Criteria

  • glaucoma patients requiring surgery (Trabeculectomy or Express Shunt; Trabeculectomy plus Phacoemulsification and Interocular Lens Implant; Baerveldt Tube; Ahmed Tube; Molteno Tube)
  • primary open angle glaucoma
  • primary angle-closure glaucoma
  • pseudoexfoliation glaucoma
  • pigmentary glaucoma
  • traumatic glaucoma
  • neovascular glaucoma

Exclusion Criteria

  • patients that are pregnant, nursing, or not using adequate contraception
  • any other eye surgery except cataract surgery
  • an infection, inflammation, or any abnormality preventing measurement of eye pressure
  • enrolled in another investigational study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00853905) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search